CN Stock MarketDetailed Quotes

600671 Hangzhou Tianmushan Pharmaceutical Enterprise

Watchlist
  • 8.86
  • +0.06+0.68%
Market Closed Dec 27 14:56 CST
1.08BMarket Cap-74.45P/E (TTM)

Hangzhou Tianmushan Pharmaceutical Enterprise Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Drug circulation23.31M39.14%
Raw material medicine14.46M24.29%
Medical device circulation7.41M12.44%
门诊服务5.06M8.50%
Chinese patent medicine4.77M8.02%
Health products4.32M7.26%
Other business207.84K0.35%
Western medicine6.8K0.01%
View all
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
药品-流通商品45.64M37.48%
Raw material31.43M25.81%
Health products16.16M13.27%
Other12.18M10.00%
Traditional Chinese medicine10.05M8.25%
Western medicine6.05M4.97%
Other256.91K0.21%
View all
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
East China region44.28M74.36%
North China8.06M13.53%
South China2.88M4.84%
Southwest area2.45M4.12%
Central China1.21M2.04%
Northeast area282.96K0.48%
Other business207.84K0.35%
Other173.81K0.29%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Traditional Chinese Medicine Concept
Traditional Chinese Medicine Concept
Intraday+0.83%
ST concept
ST concept
Intraday+0.70%
Health China
Health China
Intraday+0.41%